Novacyt announces clinical trial collaboration with the St Stephen’s AIDS Trust to expand potential market opportunities of its core NOVAprep® technology

Novacyt St Stephen’s AIDS Trust clinical trial collaboration PR ENGLISH

Paris, France and Cambridge, UK – 9 May 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, updates the market on its intentions to progress new market opportunities for its NOVAprep® technology and, in particular, a new collaboration with the UK’s National Health Service (NHS), specifically the St Stephen’s AIDS Trust Ltd, through a master agreement for clinical trials.